Nicotine Pouches: JAMA | July 2026

Introduction:

Nicotine pouches are an increasingly popular smokeless oral nicotine product marketed as an alternative to cigarettes and other tobacco products. This review summarises their composition, health effects, addiction potential, safety concerns, and current evidence regarding smoking cessation.

Why was this article needed?

• Nicotine pouch use is increasing rapidly, particularly among adults who use other nicotine products.
• Long-term safety data remain limited.
• Clinicians need guidance on counselling patients regarding nicotine pouch use.
• Their role in smoking cessation remains uncertain.
• Increasing pediatric exposures and dual-product use raise important public health concerns.

Key Takeaways:

• Nicotine pouches deliver nicotine levels comparable to cigarettes and e-cigarettes, producing significant nicotine dependence while avoiding tobacco combustion and smoke-related toxicants.
• Common adverse effects include oral irritation, mouth lesions, sore mouth, and sore throat, while the long-term risks of periodontal disease and oral cancer remain unknown.
• Nicotine pouches are frequently used alongside cigarettes and e-cigarettes, raising concerns about dual or multiple nicotine product use rather than complete smoking substitution.
• Although complete switching from cigarettes to nicotine pouches reduces exposure to many combustion-related carcinogens, there is currently no convincing evidence that nicotine pouches improve smoking cessation rates.
• Accidental ingestion by young children is increasing rapidly, with nicotine pouches associated with a higher likelihood of serious poisoning compared with many other nicotine products, emphasizing the importance of safe storage.
• Clinicians should routinely screen for nicotine pouch use and manage dependence using established smoking cessation strategies, including behavioral counseling, varenicline, and nicotine replacement therapy, while recognizing that direct evidence for nicotine pouch cessation is currently lacking.

Clinical Impact:

Nicotine pouches may represent a harm-reduction option for adult smokers who completely transition away from combustible cigarettes, but they should not be viewed as harmless products. Their increasing popularity, high nicotine delivery, addiction potential, and uncertain long-term safety underscore the need for careful patient counselling and continued surveillance.

Bottom Line:

Nicotine pouches are less harmful than combustible cigarettes because they eliminate tobacco combustion, but they are not risk-free. They can cause significant nicotine dependence, oral adverse effects, and pediatric poisoning, and their effectiveness as a smoking cessation tool has not yet been established. For smokers who completely switch, exposure to smoking-related toxicants is substantially reduced, but FDA-approved smoking cessation therapies remain the preferred first-line treatment.